STEPHANIE DESROCHES: Open Payments
NPI 1427736008 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 5 payments from 4 companies in 2025. Trend: 2023 $662 · 2024 $231 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $223 |
| Luye Pharma (USA) Ltd. | 1 | $117 |
| E.R. Squibb & Sons, L.L.C. | 1 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $80 |
Products named: INGREZZA, ERZOFRI EXTENDED-RELEASE, COBENFY.
Industry payments across MA — which companies pay providers there.
